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Q fever, a widespread zoonosis recognized as
a clinical entity in 1937 (1), is caused by the
obligate intracellular parasite, Coxiella burnetii.
The disease is endemic worldwide, occurring in
different geographic regions and climatic
zones (2). New Zealand is probably the only large
country without Q fever (3). The principal
vectors of C. burnetii are ticks, which transmit
the agent to wild animals (causing wildlife
coxiellosis) or to domestic animals (creating the
livestock reservoir of C. burnetii) (4). The most
important reservoirs in nature are small wild
rodents, but infection was also demonstrated in
insectivores, lagomorphs, carnivores, ungulates,
ruminants, marsupials, monkeys, bats, birds,
and even reptiles and fish (5,6). Infected
domestic animals (cattle, sheep, and goats but
also pet animals, especially cats), frequently
with persistent and subclinical coxiellosis,
represent the main source of C. burnetii infection
for humans, who become infected by direct
contact with these animals, by environmental
contamination (from animal excrements), and
(indirectly) through processing or consuming
animal products. Human infection is acquired
most often by the inhalation of contaminated
aerosols but may also occur through the digestive
tract, through skin trauma, or by sexual contact.
Mother-to-fetus transmission may also occur (7).
C. burnetii may cause acute and chronic
forms of Q fever in humans, though in many
cases infection is asymptomatic and confirmed
by serologic diagnosis only (8). The acute form of
Q fever manifests usually as a flulike illness or
atypical pneumonia, but often it has a protean
character with a clinical picture resembling that
of nearly any infectious disease (9). Whereas
acute Q fever is usually self-limited, chronic Q
fever is a serious and often fatal illness with
death rates exceeding 65% (10). Illness occurs
months to years after the acute infection in 1% to
11% of patients and usually manifests as
endocarditis. Infections of arterial aneurysm or
prosthesis; bone infection; pseudotumor of the
lung; hepatitis; cutaneous, musculoskeletal, or
renal involvement; and placentitis in pregnancy
with miscarriage are also possible (11).
The first human cases of Q fever in Europe
appeared in the Balkans during World War II
when strange, febrile, influenzalike infections,
named Balkangrippe, were observed among
German troops (12,13). Similar infections
occurred among allied troops during operations
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As a result of dramatic political and economic changes in the beginning of the
1990s, Q-fever epidemiology in Bulgaria has changed. The number of goats almost
tripled;  contact between goat owners (and their families) and goats, as well as goats and
other animals, increased; consumption of raw goat milk and its products increased; and
goats replaced cattle and sheep as the main source of human Coxiella burnetii
infections. Hundreds of overt, serologically confirmed human cases of acute Q fever
have occurred. Chronic forms of Q fever manifesting as endocarditis were also
observed. In contrast, in Slovakia, Q fever does not pose a serious public health
problem, and the chronic form of infection has not been found either in follow-ups of a
Q-fever epidemic connected with goats imported from Bulgaria and other previous Q-
fever outbreaks or in a serologic survey. Serologic diagnosis as well as control and
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Figure 1. Incidence of human Q fever in Bulgaria,
19831996.
Figure 2. Seasonal distribution of acute human Q-
fever cases in Bulgaria in  1983 to 1989 (dashed line)
and 1990 to 1996 (full line).
in the Mediterranean area (14,15). In the 1940s,
Q fever was recognized in Romania (16), Greece
(17), and Bulgaria (18). The Balkans thus
became the territory in which C. burnetii could
circulate in nature, be transmitted to humans,
and be spread to other parts of Europe; for
example, Q fever was probably introduced to
Slovakia through infected sheep from Romania
(6).
Q Fever in Bulgaria
Though the first human Q-fever cases in
Bulgaria were described as early as 1949 (18),
thorough epidemiologic and epizootologic studies
started later in connection with the unification of
land and livestock farms into state premises and
agricultural cooperative units. Concentration of
domestic animals (especially cows and sheep)
and conditions favoring circulation and mainte-
nance of C. burnetii in nature (ticks, reservoir
animals) turned the country into a huge natural
focus of Q fever. The occurrence of C. burnetii
infection in different parts of the country was 6%
to 100% in sheep, 5% to 31% in cattle, and 7% to
34% in goats (19), as confirmed serologically by
complement fixation (CF). Infestation of ticks
with C. burnetii reached 26% in southwest and
22% in northeast Bulgaria (20).
The situation changed dramatically in the
1990s as the large state premises and cooperative
farms collapsed and the number of cows and
sheep decreased (e.g., sheep from 8 million in
1990 to 3 million in 1997). As individual farmers
started to raise goats for easily accessible food,
the number of goats increased from 430,000 in
1990 to more than 1 million in 1997. Moreover,
the proportion of sera containing antibodies to
C. burnetii from domestic animals from five
regions of Bulgaria in 1996 to 1997 also changed;
more (90% of 140) samples from goats than from
sheep (73% of 118) tested positive. At the same
time, the rate of infestation of Dermacentor
marginatus, Ixodes ricinus, and Rhipicephalus
sanguineus with C. burnetii as demonstrated by
the hemocyte test (21) was also very high (25 of
29 ticks tested were infected).
These changes also influenced the occur-
rence and seasonality of human Q-fever cases in
Bulgaria. Until 1990, more than 20 Q-fever
outbreaks occurred in several regions of the
country, some with hundreds of patients (e.g.,
725 cases near Knyezha from 1982 to 1985 [22]
and as many as 630 cases in Pavlikeni in 1985
only). These Q-fever epidemics among farmers
explain the sharp peak of Q fever incidence in
1985 (Figure 1). A sudden drop and continual
decrease thereafter could reflect a return to a
nonepidemic situation; the gradual increase in
the 1990s was probably associated with an
increase in the number of goats (Figure 1).
Depicting the seasonality of the disease, the
number of goats shifted from winter and spring
months (December to May) with a peak in
January in the 1980s to spring and summer
months (March to August) with a peak in May
and June in the 1990s (Figure 2).
Several factors probably contributed to this
shift. 1) A change in insemination practices.
Until 1990, artificial insemination of ewes was
carried out in early autumn, but in the 1990s,
this practice was abandoned. 2) Sheep deliver in
January and February, whereas goats deliver in
March and April. 3) Herds of cattle and flocks of390 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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Table. Phase II-Coxiella burnetii antibodies in patients
with bronchopneumonia and acute respiratory symp-
toms, Bulgaria
Town Testing No. positive/  % positive
(region)  period  No.  testeda   (% acute)
Ichtiman April-June   19/21   90.5  (38)
 (West)  1995
Elin-Pelin April 1995     9/9 100.0  (44)
 (West)
Blagoyevgrad March-   26/44   59.1  (34)
 (Southwest)  June 1996
Blagoyevgrad March-   24/30   80.0  (60)
 (Southwest)  June 1997
Stara Zagora March-   24/52   46.2  (28)
 (South)  June 1997
Vraca March-   37/61   60.7  (13)
 (Northwest)  June 1997
Varna Feb-March   28/35   80.0 (14)
 (Northeast)  1997
Total 167/252   66.3 (29)
aSera from Ichtiman and Elin-Pelin were examined by
complement fixation test, remaining sera by
microagglutination. All sera were from patients with
bronchopneumonia, except those collected in Varna, which
were from patients with acute respiratory flulike symptoms.
Sera with titers ³ 10 in either test were considered
serologically positive. Acute Q-fever diagnosis was based on
seroconversion or fourfold rise of antibody titers.
sheep, though   concentrated in larger numbers,
were separated from most of the population and
served as the source of C. burnetii infection
usually among farmers and others exposed to
animals and their products. 4) An increased
number of goats have been kept in very close
contact with goat owners and their family
members. 5) Goats have been pastured daily
(from March until October), so they cross the
streets of villages and small towns twice a day.
Thus, at present in Bulgaria, goats (rather than
sheep or cattle) seem to be an important source of
C. burnetii infections for humans. Not only have
great numbers of goat owners with their families
been exposed to C. burnetii (when tending the
goats or consuming their unpasteurized milk
products), but also occasional bystanders could
contract C. burnetii infection from exposure to
the contaminated aerosols created from excre-
ments of the goats, as they repeatedly passed
through villages and small towns to their
pastures or from exposure to infectious particles
generated during parturition or abortion. For
example a Q-fever outbreak in Val de Bagnes,
Switzerland, which affected 415 persons,
occurred 3 weeks after 12 flocks of sheep
descended from the Alpine pastures to the valley
(8).
The largest Q-fever outbreak was registered
in Panagyurische (central part of southern
Bulgaria) in the 1990s, after an influenza
epidemic (end of 1992, beginning of 1993). From
January to June 1993, a second epidemic wave
with more than 2,000 cases of an acute flulike
respiratory illness and bronchopneumonia
occurred. Atypical pneumonia was diagnosed in
589 cases by X-ray examination, and 254
patients were admitted to the regional hospital.
Q fever was confirmed serologically only at the
end of the epidemic. Of more than 500 persons
who recovered from Q-feverlike disease, 60%
were seropositive; several laboratories con-
firmed significant titers (from 80 to 640 in CF
and microimmunoflourescence [MIF] tests) of
antibodies to phase II C. burnetii. Though most
of the patients and those with positive serologic
tests were adults 20 to 59 years of age, high
positivity was also noticed in children <6 years of
age (19%) and in persons 7 to 19 years of age
(23%). Most of the patients were not employed in
agriculture or the processing of animal products.
Serologic examination of domestic animals by CF
test gave similar results for goats (26% of 969)
and sheep (28% of 421). However, sheep did not
seem to serve as a source of C. burnetii
infectionthey went to pastures far away from
the town from February to March. The highest
number of human Q-fever cases was observed
from April to June when goats delivered their
kids and sporadic goat abortions occurred.
A Q-fever outbreak occurred in
Panagyurische again in April to June 1995 as
evidenced serologically in 78% of 89 patients
admitted to the local hospital with bronchopneu-
monia. Acute Q fever was diagnosed in 28 (31%)
on the basis of seroconversion or fourfold rise of
antibody titers. The results indicate that Q fever
appears to be endemic in the Panagyurische area
(with seasonal spring occurrence) and goats are
probably the main source of human infection.
Nevertheless, such a seasonal Q-fever occur-
rence has not been restricted to this area of
Bulgaria (Table) but occurred in all the regions
(Ichtiman and Elin Pelin in the West, Stara
Zagora in the South, Blagoyevgrad in the
Southwest, Vratza in the Northwest, and Varna
in the Northeast) of the country in which it had
been followed. Of 252 patients with bronchop-
neumonia and acute flulike symptoms, 66%
(46%-100%) had antibodies to phase II C. burnetii391 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
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detected by CF or microagglutination (MA) tests.
Acute Q fever was confirmed in 73 (29%) patients
tested (13% to 60% in different regions). In all
these regions, sheep, cattle, and goats have been
raised not only in villages surrounding the
above-mentioned towns, but also in their
suburbs.
Similar results were observed when testing
human sera from the serum bank. Of 224
randomly chosen sera collected in nine localities
(Gabrovo from the North, Razgrad and Dobrich
from the Northeast, Sofia from the West,
Blagoyevgrad from the Southwest, and Stara
Zagora, Pazardzhik, Haskovo, and Sliven from
the South of Bulgaria), 87 (38%) reacted
positively with phase II C. burnetii in MA or MIF
tests. Serologic positivity varied from 6% in
Sliven to 60% in Blagoyevgrad, except for
Razgrad, where none were positive (however,
only four sera were tested).
Chronic Q-fever cases manifesting as
endocarditis were confirmed serologically by
high titers from 640 to 1 ml of phase I- and phase
II- C. burnetii immunoglobulin (Ig)G antibodies
in MIF, by demonstration of specific immunof-
luorescence in the cuts of aortal valves, and by
C. burnetii isolation from the replaced prosthesis
in three patients before 1990 (23). Two additional
cases of Q-fever endocarditis were diagnosed
serologically by MA and MIF tests from 1996 to
1997.
Antibodies to phase II C. burnetii by MA
were found in 16 of 18 aborting women with
titers of 10 to 320, which indicates the possibility
of acute Q-fever infection during pregnancy. In
two cases, in paired sera collected in 23-day
intervals, a shift from the titer of 160 to
seronegativity (titer <10) was observed. Even
though abortion tissues were not cultured or
tested for C. burnetii, these findings deserve
further study, since the possible adverse effects
of  C. burnetii infection during pregnancy has
also been suggested by other authors (24).
Q Fever in Slovakia
In Slovakia, Q fever has been known since
1954 when outbreaks occurred among agricul-
tural workers who contracted the infection from
sheep imported from Romania and among
workers of a textile plant who were exposed to
contaminated imported cotton (6). From that
time until the 1980s, the waves of epizootics and
small epidemics appeared in factories processing
cotton, wool, and hides from Mongolia and
China, in a sheep farm with imported breeding
rams from England, and in various agricultural
premises often connected with excursions of
workers to cattle or sheep farms in which
C. burnetii infections could have occurred.
Veterinary and serologically uncontrolled move-
ment of cattle within the country also
contributed to the establishment of domestic
coxiellosis (25). Some areas of the southern part
of central Slovakia became a natural focus of Q
fever, with the D. marginatus tick as the main
vector of C. burnetii (6).
Since the 1980s, only sporadic cases of Q
fever have been reported from different parts of
the country, though almost 3% of approximately
7,000 ticks collected in all districts of Slovakia
were found (by the hemocyte test) to harbor
C. burnetii, and attempts to recover C. burnetii
from pooled positive ticks resulted in the
isolation of 10 virulent C. burnetii strains from
five ticks, mostly I. ricinus species (26). On the
other hand, C. burnetii strains isolated from cow
milk were of lower virulence for guinea pigs and
mice (Kováová et al., submitted for publication).
Circulation of such low virulent strains among
livestock and large-scale vaccination of cattle by
inactivated phase I-C. burnetii corpuscular
vaccine (one subcutaneous dose consisting of 500
µg of highly purified C. burnetii cells) carried out
in the 1970s and 1980s, together with improved
veterinary control of domestic animal transport
within the country, could explain a decrease in
the occurrence of human Q fever in Slovakia.
This explanation is supported by results of a
serologic survey (carried out from 1989 to 1996)
for Q-fever antibodies in groups of farmers   or in
patients with suspected C. burnetii infection. Of
21,197 human sera tested, 655 (3%) reacted with
phase II- C. burnetii antigen in the CF test (until
1992) or (later on) in enzyme-linked
immunosorbent assay (ELISA). Acute Q fever (as
individual or clustered cases) was diagnosed in
23 sera, not including 113 from the Q-fever
epidemic discussed below, on the basis of
seroconversion or IgM antibody detection.
During the same period, phase-II C. burnetii
antibodies were detected in 11% of cattle and in
3% each of sheep and goats.
Improved veterinary control of domestic
animal transport within the country, however,
cannot exclude the possibility of introducing
C. burnetii infection through imported domestic392 Emerging Infectious Diseases Vol. 5, No. 3, MayJune 1999
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animals or raw materials not tested properly.
The use of CF, which is much less sensitive to
Q-fever antibodies than other serologic tests
(e.g., ELISA [27]), to screen the goats imported to
Slovakia from Bulgaria is unsatisfactory, as
confirmed in 1993 by the largest reported
Q-fever epidemic in Slovakia (28). The epidemic
started suddenly during the spring as an
outbreak of respiratory infection in inhabitants
of a village in West Slovakia. A total of 113
persons were affected from the beginning of
March until May 18, as confirmed serologically
(seroconversion, detection of IgM antibodies, and
high phase-II antibody titers, respectively) by
CF, MA, MIF, and ELISA. Of 42 patients
admitted to the hospital, 33 had atypical
pneumonia (diagnosed by X-ray examination),
and 27 had hepatic involvement (diagnosed on
the basis of the increased values of liver
transaminases). As many as 103 were male
patients who used to visit the local pub, in which
they contracted infection by the aerosol created
from the heavily contaminated garments of boys
tending aborting goats. C. burnetii infection in
incriminated goats was confirmed serologically
(46 of 216 goat sera tested were positive by
ELISA) and by seroconversion in mice inoculated
with spleen, lung, and liver suspension from an
aborted kid.
In contrast to the situation in Bulgaria, a 4-
year follow-up of patients from this Q-fever
epidemic did not result in clinical or serologic
confirmation of any chronic form of the disease
(Kováová  et al., submitted for publication). In
addition,  evidence of chronic Q fever was
obtained neither in the serologic survey carried
out in Slovakia from 1989 to 1996, nor in testing
of more than 200 patients with chronic
cardiovascular disease (some of them exposed to
C. burnetii infection through their work).
Similarly, observation of patients from other
Q-fever epidemics (including those with 98 cases
in a cotton-processing plant in nearby Southern
Moravia in 1980 [29]) was also negative.
Whether this can be explained by C. burnetii
strains of different virulence circulating in
Bulgaria and Slovakia, respectively, remains to
be seen, though in the latest Q-fever epidemic in
West Slovakia, Bulgarian C. burnetii strains
were presumably involved. However, whereas
C. burnetii strains of tick and domestic animals
origin isolated in Slovakia may differ, no data are
known on the virulence of Bulgarian strains. A
total number of human C. burnetii cases can also
be important. Whereas in Bulgaria more than
1,000 patients were affected, in Slovakia tens of
human cases occurred, so the probability of
developing the chronic form of Q fever in
Slovakia was lower. The small number of
patients in Slovakia could also be explained by
earlier diagnosis and proper antibiotic treatment
at the early stage of infection. The patients
history, e.g., previous rheumatic disease, should
be also taken into consideration.
Lessons Learned from Q-Fever Outbreaks
in Bulgaria and Slovakia
Epidemiologic and serologic investigations in
Bulgaria and Slovakia indicate that an increase
in human Q fever in Bulgaria in the 1990s and
Slovakia in 1993 was associated with goats. The
data on the propensity of goats to transmit
C. burnetii to humans from Greece, Cyprus,
France, the United States, and even a trans-
Pacific cargo ship transporting dairy goats, were
summarized by Lang (4). More recently, a cluster
of human C. burnetii infections associated with
exposure to vaccinated goats and their unpas-
teurized products was reported from France (30).
Goats may pose a threat to human health as a
source of C. burnetii infection in every country in
which they are raised extensively and are in
close contact with humans. However, Q fever can
also be contracted from other sources of infection
and has been, even in Bulgaria and Slovakia.
Reporting of Q fever in a given territory
depends on the attention of public health
authorities and the availability of diagnostic
methods. Apart from C. burnetii isolation
(mainly in cell cultures by a shell-vial method
[31] or direct detection, preferably by polymerase
chain reaction [32]), these diagnostic methods
are based mostly on serologic tests. Sensitivity of
serologic tests for screening Q-fever antibodies
increased from CF to MA and from MIF to ELISA
(27). The cut-off values for individual tests may
differ between laboratories and antigens used;
for CF and MA tests, 1:8 and 1:16 serum
dilutions were acceptable (in Slovakia) and for
either test 1:10 serum dilution was acceptable (in
Bulgaria). For a more sensitive MIF and ELISA
allowing also detection of immunoglobulin
classes, diagnostic titers were set at the phase-II
IgG ³ 200 and phase-II IgM ³ 50 in MIF (33) and
at  ³ 128 for the IgM and IgG phase-I responses,
but ³ 512 for the IgM and ³ 1,024 for the IgG393 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
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response to phase II C. burnetii in ELISA (34),
respectively. Serologic diagnosis of acute Q fever
relies on seroconversion from negativity to
positivity or at least fourfold rise of phase-II
antibodies in paired (acute- and convalescent-
phase) serum samples and demonstration of IgM
antibody response or high titers (e.g., ³ 128 in CF
and  200 in MIF) of phase-II antibodies in a single
serum sample. For diagnosis of chronic Q fever,
high titers (i.e., ³ 200  in CF and ³ 800 of in MIF)
of phase I antibodies, occurring rarely and in low
titers in acute Q-fever cases, are required (9).
Q-fever control and prevention measures
have been reviewed (35). Apart from the
thorough control of imported domestic animals,
raw materials, and movement of domestic
animals within a country, prevention measures
should include adequate disinfection and
disposal of animal products of conception and
strict hygienic measures in cattle, sheep, and
goat farms; plants processing products of these
animals; boiling or pasteurization of milk at
62.8°C for 30 minutes or at 71.7°C for 15 seconds;
and vaccination. At present, three types of Q-
fever vaccine are available for human use: a
Formalin-inactivated whole-cell phase-I
C.  burnetii vaccine used in Australia (36), a
chloroform-methanol residue subunit of phase-I
C. burnetii recommended by American authors
(37), and Q-fever chemovaccine (a soluble
subunit vaccine obtained by treatment with
trichloroacetic acid of phase-I cells) developed
and used in Romania (38) and the former
Czechoslovakia (39). For vaccination of domestic
animals, corpuscular phase I (in Slovakia) or
phase II (e.g., in France) were used. The fact that
phase-II vaccine did not protect goats from
shedding  C. burnetii in milk (30) confirmed that
an effective Q-fever vaccine should consist of or
be prepared from phase-I C. burnetii (40).
Efficient recombinant vaccines, however, should
also be pursued.
Mass vaccination of cattle in Slovakia in the
1970s, followed by selective vaccination of cattle
in serologically positive herds and elimination of
positive reactors in the 1980s could lessen not
only distribution of C. burnetii among domestic
animals, but also its transmission to humans.
However, absence of vaccination of domestic
animals in Bulgaria could contribute to the
maintenance of C. burnetii and therefore to
increased possibility of human infection, though
basic natural conditions for circulation of this
agent in either country have been similar.
Moreover, gradual changes in agriculture in
Slovakia during the 1990s resulted in reduced
numbers of cattle and sheep but not in the
dramatic increase in goat numbers seen in
Bulgaria after the collapse of state farms and
cooperative units. One can conclude that in
Bulgaria there is a permanent threat of more Q-
fever outbreaks unless preventive measures,
including improvement of veterinary services
and vaccination of domestic animals, particu-
larly goats, are established. In Slovakia, because
of surveillance, veterinary control, and vaccina-
tion of domestic animals, the situation is much
better; however, attention should still be paid to
avoid introduction of C. burnetii by imported
animals and raw materials and the possibility of
coxiellosis outbreaks among domestic animals
and consequently Q fever in humans.
Dr. Serbezov is consultant at the National Center
of Infectious and Parasitic Diseases in Sofia.
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